[ RECIPIENT ENTITY RECORD ]

Cerevel Therapeutics

VERIFIED NODE ID: 001728 · cerevel-therapeutics
R TARGET NODE — CAPITAL RECIPIENT
Cerevel Therapeutics
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Cerevel Therapeutics
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Cerevel Therapeutics is a biopharmaceutical company that leverages its deep understanding of neuroscience to develop transformative therapies for brain disorders. Based in Massachusetts, the firm has a diverse pipeline targeting Parkinson’s disease and epilepsy. It was a major recipient of institutional healthcare capital through its acquisition by a global major.

Capital Influx Log (Transactions)
Date Type Amount
22 May 2026 EQUITY $8.7B